We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
+12.98%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$95.4B
AUM Growth
+$9.26B
(+11%)
Cap. Flow
-$707M
Cap. Flow
% of AUM
-0.74%
Top 10 Holdings %
Top 10 Hldgs %
25.21%
Holding
4,380
New
32
Increased
1,513
Reduced
2,146
Closed
67
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 1000 ETF
IWB
|
+$99.9M |
| 2 |
Uber
UBER
|
+$71M |
| 3 |
Broadcom
AVGO
|
+$36.2M |
| 4 |
iShares Russell 2000 ETF
IWM
|
+$32.6M |
| 5 |
lululemon athletica
LULU
|
+$32.3M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ATVI
Activision Blizzard
ATVI
|
+$139M |
| 2 |
Apple
AAPL
|
+$72.7M |
| 3 |
VMW
VMware, Inc
VMW
|
+$47.1M |
| 4 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$42.3M |
| 5 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$35.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.73% |
| 2 | Financials | 13% |
| 3 | Healthcare | 12.09% |
| 4 | Consumer Discretionary | 11.32% |
| 5 | Industrials | 9.44% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2101
BioLife Solutions
BLFS
$1.7B
| $1.34M | ﹤0.01% |
82,574
+2,207
| +3% | +$28.2K |
|
2102
Editas Medicine
EDIT
$442M
| $1.33M | ﹤0.01% |
131,386
-33
| -0% | -$290 |
|
2103
Dream Finders Homes
DFH
$1.36B
| $1.32M | ﹤0.01% |
37,279
+3,025
| +9% | +$75.3K |
|
2104
Hovnanian Enterprises
HOV
$807M
| $1.32M | ﹤0.01% |
8,501
-3
| -0% | -$302 |
|
|
EU
2105
enCore Energy
EU
$243M
| $1.32M | ﹤0.01% |
336,023
-59,119
| -15% | -$210K |
|
|
AXA
2106
DELISTED
AXA ADS (1 ORD SHS)
AXA
| $1.32M | ﹤0.01% |
40,294
+5,804
| +17% | +$190K |
|
|
ROVR
2107
DELISTED
Rover Group, Inc. Class A Common Stock
ROVR
| $1.32M | ﹤0.01% |
121,048
-401
| -0.3% | -$3.39K |
|
2108
Victory Capital Holdings
VCTR
$6.65B
| $1.32M | ﹤0.01% |
38,239
-301
| -0.8% | -$9.63K |
|
2109
Viridian Therapeutics
VRDN
$2.67B
| $1.32M | ﹤0.01% |
60,434
-63
| -0.1% | -$995 |
|
2110
ADMA Biologics
ADMA
$2.22B
| $1.3M | ﹤0.01% |
288,347
+617
| +0.2% | +$2.28K |
|
|
ETWO
2111
DELISTED
E2open Parent Holdings
ETWO
| $1.3M | ﹤0.01% |
296,831
+1,177
| +0.4% | +$4.18K |
|
|
DCPH
2112
DELISTED
Deciphera Pharmaceuticals, Inc. Common Stock
DCPH
| $1.3M | ﹤0.01% |
80,785
-10
| -0% | -$128 |
|
|
FBMS
2113
DELISTED
The First Bancshares, Inc.
FBMS
| $1.3M | ﹤0.01% |
44,300
+112
| +0.3% | +$3K |
|
2114
Select Water Solutions
WTTR
$2.61B
| $1.3M | ﹤0.01% |
171,001
-6,005
| -3% | -$44.7K |
|
2115
F&G Annuities & Life
FG
$3.62B
| $1.29M | ﹤0.01% |
28,122
+723
| +3% | +$27K |
|
2116
BHP
BHP
$230B
| $1.29M | ﹤0.01% |
18,919
+176
| +0.9% | +$10.6K |
|
|
RDUS
2117
DELISTED
Radius Recycling
RDUS
| $1.29M | ﹤0.01% |
42,846
+14
| +0% | +$369 |
|
2118
Amneal Pharmaceuticals
AMRX
$5.79B
| $1.29M | ﹤0.01% |
212,791
+13,386
| +7% | +$59.6K |
|
2119
NovaGold Resources
NG
$3.33B
| $1.28M | ﹤0.01% |
341,776
+12,710
| +4% | +$47.7K |
|
|
DAWN
2120
DELISTED
Day One Biopharmaceuticals
DAWN
| $1.28M | ﹤0.01% |
87,434
-1,769
| -2% | -$21.4K |
|
2121
VSE Corp
VSEC
$6.12B
| $1.26M | ﹤0.01% |
19,571
+229
| +1% | +$13.4K |
|
2122
Navitas Semiconductor
NVTS
$3.63B
| $1.26M | ﹤0.01% |
156,673
+3,722
| +2% | +$25K |
|
|
FLNA
2123
Filana Therapeutics
FLNA
$48.1M
| $1.26M | ﹤0.01% |
56,102
-647
| -1% | -$13.7K |
|
2124
ING
ING
$102B
| $1.26M | ﹤0.01% |
83,846
-525
| -0.6% | -$7.21K |
|
2125
Aspen Aerogels
ASPN
$518M
| $1.26M | ﹤0.01% |
79,782
+3,665
| +5% | +$37.8K |
|
Similar funds
VAM
RhumbLine Advisers's Q4 2023 Portfolio in Review
As of Q4 2023, RhumbLine Advisers held 4,380 positions worth $95.4B, up 11% from $86.2B the previous quarter. Its ten largest holdings account for 25% of the portfolio.
Trading was light in Q4 2023: portfolio turnover was 2.3%. RhumbLine Advisers opened 32 new positions and exited 67, leaving the 4,380-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 27% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q4 2023 buy was CRH: 83,048 shares worth $5.74M.
- RhumbLine Advisers added most to iShares Russell 1000 ETF in Q4 2023, an estimated $99.9M increase.
- RhumbLine Advisers's biggest Q4 2023 reduction was Apple, cutting an estimated $72.7M.
- RhumbLine Advisers fully exited Activision Blizzard in Q4 2023, selling an estimated $139M.
- RhumbLine Advisers's ten largest holdings make up 25% of its $95.4B portfolio in Q4 2023.
- RhumbLine Advisers opened 32 new positions and closed 67 in Q4 2023.
- RhumbLine Advisers's portfolio value rose 11% quarter-over-quarter to $95.4B.
Based on RhumbLine Advisers's 13F filing for Q4 2023, filed 8 Feb 2024.